2012-2023 Global Prosthetic Heart Valves Market

Prosthetic Heart Valves Comprehensive Study by Type (Transcatheter Heart Valve, Tissue Heart Valve, Mechanical Heart Valve), End User (Hospitals, Ambulatory Surgical Centers, Others) Players and Region - Global Market Outlook to 2026

Prosthetic Heart Valves Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Prosthetic Heart Valves Market Scope?
Increasing Aging Population and occurrence of valvular disease spur the growth of the global prosthetic heart valve market in the forecasted period. Prosthetic heart valve, also called as an artificial heart valve, is fixed in the heart of an individual with cardiac vascular disease. It is made of strong material including carbon or titanium. The prosthetic heart valve is a medical device that transplants in the heart disease patient who is suffering from heart failure. It provides a heart valve consists of orifices, which are provided blood flow. Growing lifestyle diseases, smoking population, rising aging population are the key driver of prosthetic heart valves market. Growing demand for minimally-invasive devices and upsurge in occurrences of cardiac valve disorders are projected to create opportunities in the forecasted period.

The Prosthetic Heart Valves market study is being classified by Type (Transcatheter Heart Valve, Tissue Heart Valve and Mechanical Heart Valve) and major geographies with country level break-up.

The global prosthetic heart valve market is very fragmented and the key players have used many strategies including new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their market share in this market. Research Analyst at AMA predicts that Players from United States will contribute to the maximum growth of Global Prosthetic Heart Valves market throughout the predicted period.

Medtronic plc (Ireland), Boston Scientific Corporation (United States), Edwards Lifesciences Corporation (United States), St. Jude Medical, Inc. (an Abbott Laboratories Company) (United States), Symetis SA (Switzerland), LivaNova PLC (United Kingdom), Jenavalve Technology, Inc. (Germany), TTK Healthcare Limited (India), CryoLife, Inc. (United States) and Colibri Heart Valve, LLC (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Braile Biomédica (Brazil) and Lepu Medical Technology Co., Ltd. (China).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Prosthetic Heart Valves market by Type, Application and Region.

On the basis of geography, the market of Prosthetic Heart Valves has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2020. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement.

Market Influencers and their development strategies
On 23rd April 2019, The U.S. Food and Drug Administration (FDA) has cleared the Boston Scientific Lotus Edge transcatheter aortic valve system. Delivered via a minimally invasive procedure, this transcatheter aortic valve replacement (TAVR) technology is approved for patients with severe aortic stenosis who are considered at high risk for surgical valve replacement via open heart surgery.
On 6th March 2018, Abbott has announced the U.S. Food and Drug Administration (FDA) approved the Masters HP™ 15mm rotatable mechanical heart valve, the world's smallest mechanical heart valve, that will allow doctors to treat babies and toddlers in need of a mitral or aortic valve replacement.


Influencing Market Trend
  • Favorable Reimbursement Scenario for Prosthetic Heart Valve
  • Technological Advancements in Products

Market Drivers
  • Increasing Awareness about Prosthetic Heart Valves Diseases
  • Rising Government Expenditure for Heart Diseases

Opportunities
  • Increasing Indication of TAVR from Only High-Risk to Intermediate- Or Low-Risk Patients
  • Robust Product Pipeline
  • Development Potential Offered By Emerging Nations
  • Growing Investments by Key Players in Emerging Companies

Restraints
  • Expensive Procedure of Transcatheter Aortic Valve Replacement (TAVR)
  • Availability of Various Methods for Treatment

Challenges
  • Introduction of Tissue-Engineered Heart Valve (TEHV)
  • Need for Skilled Cardiac Specialist


Key Target Audience
Prosthetic Heart Valve Manufacturing Companies, Suppliers and Distributors of Prosthetic Heart Valve, Healthcare Service Providers, Teaching Hospitals and Academic Medical Centers (AMCs), Health Insurance Players, Investment Research Firms, Government and Private Research Organization, Government Regulatory Bodies and Others

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • Transcatheter Heart Valve
  • Tissue Heart Valve
  • Mechanical Heart Valve
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Awareness about Prosthetic Heart Valves Diseases
      • 3.2.2. Rising Government Expenditure for Heart Diseases
    • 3.3. Market Challenges
      • 3.3.1. Introduction of Tissue-Engineered Heart Valve (TEHV)
      • 3.3.2. Need for Skilled Cardiac Specialist
    • 3.4. Market Trends
      • 3.4.1. Favorable Reimbursement Scenario for Prosthetic Heart Valve
      • 3.4.2. Technological Advancements in Products
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Prosthetic Heart Valves, by Type, End User and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Prosthetic Heart Valves (Value)
      • 5.2.1. Global Prosthetic Heart Valves by: Type (Value)
        • 5.2.1.1. Transcatheter Heart Valve
        • 5.2.1.2. Tissue Heart Valve
        • 5.2.1.3. Mechanical Heart Valve
      • 5.2.2. Global Prosthetic Heart Valves by: End User (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Ambulatory Surgical Centers
        • 5.2.2.3. Others
      • 5.2.3. Global Prosthetic Heart Valves Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Prosthetic Heart Valves: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Medtronic plc (Ireland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Boston Scientific Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Edwards Lifesciences Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. St. Jude Medical, Inc. (an Abbott Laboratories Company) (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Symetis SA (Switzerland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. LivaNova PLC (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Jenavalve Technology, Inc. (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. TTK Healthcare Limited (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. CryoLife, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Colibri Heart Valve, LLC (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Prosthetic Heart Valves Sale, by Type, End User and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Prosthetic Heart Valves (Value)
      • 7.2.1. Global Prosthetic Heart Valves by: Type (Value)
        • 7.2.1.1. Transcatheter Heart Valve
        • 7.2.1.2. Tissue Heart Valve
        • 7.2.1.3. Mechanical Heart Valve
      • 7.2.2. Global Prosthetic Heart Valves by: End User (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Ambulatory Surgical Centers
        • 7.2.2.3. Others
      • 7.2.3. Global Prosthetic Heart Valves Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Prosthetic Heart Valves: by Type(USD Million)
  • Table 2. Prosthetic Heart Valves Transcatheter Heart Valve , by Region USD Million (2015-2020)
  • Table 3. Prosthetic Heart Valves Tissue Heart Valve , by Region USD Million (2015-2020)
  • Table 4. Prosthetic Heart Valves Mechanical Heart Valve , by Region USD Million (2015-2020)
  • Table 5. Prosthetic Heart Valves: by End User(USD Million)
  • Table 6. Prosthetic Heart Valves Hospitals , by Region USD Million (2015-2020)
  • Table 7. Prosthetic Heart Valves Ambulatory Surgical Centers , by Region USD Million (2015-2020)
  • Table 8. Prosthetic Heart Valves Others , by Region USD Million (2015-2020)
  • Table 9. South America Prosthetic Heart Valves, by Country USD Million (2015-2020)
  • Table 10. South America Prosthetic Heart Valves, by Type USD Million (2015-2020)
  • Table 11. South America Prosthetic Heart Valves, by End User USD Million (2015-2020)
  • Table 12. Brazil Prosthetic Heart Valves, by Type USD Million (2015-2020)
  • Table 13. Brazil Prosthetic Heart Valves, by End User USD Million (2015-2020)
  • Table 14. Argentina Prosthetic Heart Valves, by Type USD Million (2015-2020)
  • Table 15. Argentina Prosthetic Heart Valves, by End User USD Million (2015-2020)
  • Table 16. Rest of South America Prosthetic Heart Valves, by Type USD Million (2015-2020)
  • Table 17. Rest of South America Prosthetic Heart Valves, by End User USD Million (2015-2020)
  • Table 18. Asia Pacific Prosthetic Heart Valves, by Country USD Million (2015-2020)
  • Table 19. Asia Pacific Prosthetic Heart Valves, by Type USD Million (2015-2020)
  • Table 20. Asia Pacific Prosthetic Heart Valves, by End User USD Million (2015-2020)
  • Table 21. China Prosthetic Heart Valves, by Type USD Million (2015-2020)
  • Table 22. China Prosthetic Heart Valves, by End User USD Million (2015-2020)
  • Table 23. Japan Prosthetic Heart Valves, by Type USD Million (2015-2020)
  • Table 24. Japan Prosthetic Heart Valves, by End User USD Million (2015-2020)
  • Table 25. India Prosthetic Heart Valves, by Type USD Million (2015-2020)
  • Table 26. India Prosthetic Heart Valves, by End User USD Million (2015-2020)
  • Table 27. South Korea Prosthetic Heart Valves, by Type USD Million (2015-2020)
  • Table 28. South Korea Prosthetic Heart Valves, by End User USD Million (2015-2020)
  • Table 29. Taiwan Prosthetic Heart Valves, by Type USD Million (2015-2020)
  • Table 30. Taiwan Prosthetic Heart Valves, by End User USD Million (2015-2020)
  • Table 31. Australia Prosthetic Heart Valves, by Type USD Million (2015-2020)
  • Table 32. Australia Prosthetic Heart Valves, by End User USD Million (2015-2020)
  • Table 33. Rest of Asia-Pacific Prosthetic Heart Valves, by Type USD Million (2015-2020)
  • Table 34. Rest of Asia-Pacific Prosthetic Heart Valves, by End User USD Million (2015-2020)
  • Table 35. Europe Prosthetic Heart Valves, by Country USD Million (2015-2020)
  • Table 36. Europe Prosthetic Heart Valves, by Type USD Million (2015-2020)
  • Table 37. Europe Prosthetic Heart Valves, by End User USD Million (2015-2020)
  • Table 38. Germany Prosthetic Heart Valves, by Type USD Million (2015-2020)
  • Table 39. Germany Prosthetic Heart Valves, by End User USD Million (2015-2020)
  • Table 40. France Prosthetic Heart Valves, by Type USD Million (2015-2020)
  • Table 41. France Prosthetic Heart Valves, by End User USD Million (2015-2020)
  • Table 42. Italy Prosthetic Heart Valves, by Type USD Million (2015-2020)
  • Table 43. Italy Prosthetic Heart Valves, by End User USD Million (2015-2020)
  • Table 44. United Kingdom Prosthetic Heart Valves, by Type USD Million (2015-2020)
  • Table 45. United Kingdom Prosthetic Heart Valves, by End User USD Million (2015-2020)
  • Table 46. Netherlands Prosthetic Heart Valves, by Type USD Million (2015-2020)
  • Table 47. Netherlands Prosthetic Heart Valves, by End User USD Million (2015-2020)
  • Table 48. Rest of Europe Prosthetic Heart Valves, by Type USD Million (2015-2020)
  • Table 49. Rest of Europe Prosthetic Heart Valves, by End User USD Million (2015-2020)
  • Table 50. MEA Prosthetic Heart Valves, by Country USD Million (2015-2020)
  • Table 51. MEA Prosthetic Heart Valves, by Type USD Million (2015-2020)
  • Table 52. MEA Prosthetic Heart Valves, by End User USD Million (2015-2020)
  • Table 53. Middle East Prosthetic Heart Valves, by Type USD Million (2015-2020)
  • Table 54. Middle East Prosthetic Heart Valves, by End User USD Million (2015-2020)
  • Table 55. Africa Prosthetic Heart Valves, by Type USD Million (2015-2020)
  • Table 56. Africa Prosthetic Heart Valves, by End User USD Million (2015-2020)
  • Table 57. North America Prosthetic Heart Valves, by Country USD Million (2015-2020)
  • Table 58. North America Prosthetic Heart Valves, by Type USD Million (2015-2020)
  • Table 59. North America Prosthetic Heart Valves, by End User USD Million (2015-2020)
  • Table 60. United States Prosthetic Heart Valves, by Type USD Million (2015-2020)
  • Table 61. United States Prosthetic Heart Valves, by End User USD Million (2015-2020)
  • Table 62. Canada Prosthetic Heart Valves, by Type USD Million (2015-2020)
  • Table 63. Canada Prosthetic Heart Valves, by End User USD Million (2015-2020)
  • Table 64. Mexico Prosthetic Heart Valves, by Type USD Million (2015-2020)
  • Table 65. Mexico Prosthetic Heart Valves, by End User USD Million (2015-2020)
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Prosthetic Heart Valves: by Type(USD Million)
  • Table 77. Prosthetic Heart Valves Transcatheter Heart Valve , by Region USD Million (2021-2026)
  • Table 78. Prosthetic Heart Valves Tissue Heart Valve , by Region USD Million (2021-2026)
  • Table 79. Prosthetic Heart Valves Mechanical Heart Valve , by Region USD Million (2021-2026)
  • Table 80. Prosthetic Heart Valves: by End User(USD Million)
  • Table 81. Prosthetic Heart Valves Hospitals , by Region USD Million (2021-2026)
  • Table 82. Prosthetic Heart Valves Ambulatory Surgical Centers , by Region USD Million (2021-2026)
  • Table 83. Prosthetic Heart Valves Others , by Region USD Million (2021-2026)
  • Table 84. South America Prosthetic Heart Valves, by Country USD Million (2021-2026)
  • Table 85. South America Prosthetic Heart Valves, by Type USD Million (2021-2026)
  • Table 86. South America Prosthetic Heart Valves, by End User USD Million (2021-2026)
  • Table 87. Brazil Prosthetic Heart Valves, by Type USD Million (2021-2026)
  • Table 88. Brazil Prosthetic Heart Valves, by End User USD Million (2021-2026)
  • Table 89. Argentina Prosthetic Heart Valves, by Type USD Million (2021-2026)
  • Table 90. Argentina Prosthetic Heart Valves, by End User USD Million (2021-2026)
  • Table 91. Rest of South America Prosthetic Heart Valves, by Type USD Million (2021-2026)
  • Table 92. Rest of South America Prosthetic Heart Valves, by End User USD Million (2021-2026)
  • Table 93. Asia Pacific Prosthetic Heart Valves, by Country USD Million (2021-2026)
  • Table 94. Asia Pacific Prosthetic Heart Valves, by Type USD Million (2021-2026)
  • Table 95. Asia Pacific Prosthetic Heart Valves, by End User USD Million (2021-2026)
  • Table 96. China Prosthetic Heart Valves, by Type USD Million (2021-2026)
  • Table 97. China Prosthetic Heart Valves, by End User USD Million (2021-2026)
  • Table 98. Japan Prosthetic Heart Valves, by Type USD Million (2021-2026)
  • Table 99. Japan Prosthetic Heart Valves, by End User USD Million (2021-2026)
  • Table 100. India Prosthetic Heart Valves, by Type USD Million (2021-2026)
  • Table 101. India Prosthetic Heart Valves, by End User USD Million (2021-2026)
  • Table 102. South Korea Prosthetic Heart Valves, by Type USD Million (2021-2026)
  • Table 103. South Korea Prosthetic Heart Valves, by End User USD Million (2021-2026)
  • Table 104. Taiwan Prosthetic Heart Valves, by Type USD Million (2021-2026)
  • Table 105. Taiwan Prosthetic Heart Valves, by End User USD Million (2021-2026)
  • Table 106. Australia Prosthetic Heart Valves, by Type USD Million (2021-2026)
  • Table 107. Australia Prosthetic Heart Valves, by End User USD Million (2021-2026)
  • Table 108. Rest of Asia-Pacific Prosthetic Heart Valves, by Type USD Million (2021-2026)
  • Table 109. Rest of Asia-Pacific Prosthetic Heart Valves, by End User USD Million (2021-2026)
  • Table 110. Europe Prosthetic Heart Valves, by Country USD Million (2021-2026)
  • Table 111. Europe Prosthetic Heart Valves, by Type USD Million (2021-2026)
  • Table 112. Europe Prosthetic Heart Valves, by End User USD Million (2021-2026)
  • Table 113. Germany Prosthetic Heart Valves, by Type USD Million (2021-2026)
  • Table 114. Germany Prosthetic Heart Valves, by End User USD Million (2021-2026)
  • Table 115. France Prosthetic Heart Valves, by Type USD Million (2021-2026)
  • Table 116. France Prosthetic Heart Valves, by End User USD Million (2021-2026)
  • Table 117. Italy Prosthetic Heart Valves, by Type USD Million (2021-2026)
  • Table 118. Italy Prosthetic Heart Valves, by End User USD Million (2021-2026)
  • Table 119. United Kingdom Prosthetic Heart Valves, by Type USD Million (2021-2026)
  • Table 120. United Kingdom Prosthetic Heart Valves, by End User USD Million (2021-2026)
  • Table 121. Netherlands Prosthetic Heart Valves, by Type USD Million (2021-2026)
  • Table 122. Netherlands Prosthetic Heart Valves, by End User USD Million (2021-2026)
  • Table 123. Rest of Europe Prosthetic Heart Valves, by Type USD Million (2021-2026)
  • Table 124. Rest of Europe Prosthetic Heart Valves, by End User USD Million (2021-2026)
  • Table 125. MEA Prosthetic Heart Valves, by Country USD Million (2021-2026)
  • Table 126. MEA Prosthetic Heart Valves, by Type USD Million (2021-2026)
  • Table 127. MEA Prosthetic Heart Valves, by End User USD Million (2021-2026)
  • Table 128. Middle East Prosthetic Heart Valves, by Type USD Million (2021-2026)
  • Table 129. Middle East Prosthetic Heart Valves, by End User USD Million (2021-2026)
  • Table 130. Africa Prosthetic Heart Valves, by Type USD Million (2021-2026)
  • Table 131. Africa Prosthetic Heart Valves, by End User USD Million (2021-2026)
  • Table 132. North America Prosthetic Heart Valves, by Country USD Million (2021-2026)
  • Table 133. North America Prosthetic Heart Valves, by Type USD Million (2021-2026)
  • Table 134. North America Prosthetic Heart Valves, by End User USD Million (2021-2026)
  • Table 135. United States Prosthetic Heart Valves, by Type USD Million (2021-2026)
  • Table 136. United States Prosthetic Heart Valves, by End User USD Million (2021-2026)
  • Table 137. Canada Prosthetic Heart Valves, by Type USD Million (2021-2026)
  • Table 138. Canada Prosthetic Heart Valves, by End User USD Million (2021-2026)
  • Table 139. Mexico Prosthetic Heart Valves, by Type USD Million (2021-2026)
  • Table 140. Mexico Prosthetic Heart Valves, by End User USD Million (2021-2026)
  • Table 141. Research Programs/Design for This Report
  • Table 142. Key Data Information from Secondary Sources
  • Table 143. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Prosthetic Heart Valves: by Type USD Million (2015-2020)
  • Figure 5. Global Prosthetic Heart Valves: by End User USD Million (2015-2020)
  • Figure 6. South America Prosthetic Heart Valves Share (%), by Country
  • Figure 7. Asia Pacific Prosthetic Heart Valves Share (%), by Country
  • Figure 8. Europe Prosthetic Heart Valves Share (%), by Country
  • Figure 9. MEA Prosthetic Heart Valves Share (%), by Country
  • Figure 10. North America Prosthetic Heart Valves Share (%), by Country
  • Figure 11. Global Prosthetic Heart Valves share by Players 2020 (%)
  • Figure 12. Global Prosthetic Heart Valves share by Players (Top 3) 2020(%)
  • Figure 13. Global Prosthetic Heart Valves share by Players (Top 5) 2020(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Medtronic plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 16. Medtronic plc (Ireland) Revenue: by Geography 2020
  • Figure 17. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 18. Boston Scientific Corporation (United States) Revenue: by Geography 2020
  • Figure 19. Edwards Lifesciences Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 20. Edwards Lifesciences Corporation (United States) Revenue: by Geography 2020
  • Figure 21. St. Jude Medical, Inc. (an Abbott Laboratories Company) (United States) Revenue, Net Income and Gross profit
  • Figure 22. St. Jude Medical, Inc. (an Abbott Laboratories Company) (United States) Revenue: by Geography 2020
  • Figure 23. Symetis SA (Switzerland) Revenue, Net Income and Gross profit
  • Figure 24. Symetis SA (Switzerland) Revenue: by Geography 2020
  • Figure 25. LivaNova PLC (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 26. LivaNova PLC (United Kingdom) Revenue: by Geography 2020
  • Figure 27. Jenavalve Technology, Inc. (Germany) Revenue, Net Income and Gross profit
  • Figure 28. Jenavalve Technology, Inc. (Germany) Revenue: by Geography 2020
  • Figure 29. TTK Healthcare Limited (India) Revenue, Net Income and Gross profit
  • Figure 30. TTK Healthcare Limited (India) Revenue: by Geography 2020
  • Figure 31. CryoLife, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. CryoLife, Inc. (United States) Revenue: by Geography 2020
  • Figure 33. Colibri Heart Valve, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 34. Colibri Heart Valve, LLC (United States) Revenue: by Geography 2020
  • Figure 35. Global Prosthetic Heart Valves: by Type USD Million (2021-2026)
  • Figure 36. Global Prosthetic Heart Valves: by End User USD Million (2021-2026)
  • Figure 37. South America Prosthetic Heart Valves Share (%), by Country
  • Figure 38. Asia Pacific Prosthetic Heart Valves Share (%), by Country
  • Figure 39. Europe Prosthetic Heart Valves Share (%), by Country
  • Figure 40. MEA Prosthetic Heart Valves Share (%), by Country
  • Figure 41. North America Prosthetic Heart Valves Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Medtronic plc (Ireland)
  • Boston Scientific Corporation (United States)
  • Edwards Lifesciences Corporation (United States)
  • St. Jude Medical, Inc. (an Abbott Laboratories Company) (United States)
  • Symetis SA (Switzerland)
  • LivaNova PLC (United Kingdom)
  • Jenavalve Technology, Inc. (Germany)
  • TTK Healthcare Limited (India)
  • CryoLife, Inc. (United States)
  • Colibri Heart Valve, LLC (United States)
Additional players considered in the study are as follows:
Braile Biomédica (Brazil) , Lepu Medical Technology Co., Ltd. (China)
Select User Access Type

Key Highlights of Report


Jan 2021 229 Pages 80 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
2012-2023 Global Prosthetic Heart Valves Market Quantitative research analysis
2012-2023 Global Prosthetic Heart Valves Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About 2012-2023 Global Prosthetic Heart Valves Market Report?

Have a Query? Click Here

Other Related Reports

Cystoscope Comprehensive Study by Type (Rigid Cystoscope, Flexible Cystoscope), Application (Urology, Gynaecology), End User (Hospitals & Clinics, Ambulatory Surgical Centers) Players and Region - Gl...
$ 3500
Diuretics Comprehensive Study by Type (Thiazide diuretics, Loop diuretics, Potassium-sparing diuretics), Application (Hypertension, Edema, Hypercalciuria, Diabetes, Insipidus, Others), Distribution C...
$ 3750
Therapeutic Vaccines Comprehensive Study by Category (Antigen Vaccines, Dendritic Cell Vaccines, DNA Vaccines, Tumor Cell Vaccines), Disease (Autoimmune Disease, Cancer, Neurological Diseases, Infect...
$ 3650
Traumatic Brain Injury Therapeutics Comprehensive Study by Type (Immediate emergency care, Medications (Diuretics, Anti-seizure drugs, Coma-inducing drugs, Anti-anxiety agents, Antidepressants, Anti-...
$ 3800
ENT Disorder Treatment Comprehensive Study by Type (Devices, Therapy, Medications (Nasal Spray, Drops, Tablets), Others), Application (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Setti...
$ 3650
Scar Treatment Comprehensive Study by Type (Surgical, Laser, Topical, Injectable, Other), Application (Hospitals, Dermatology Clinics, Other), Scar (Atrophic, Hypertrophic and Keloid, Contracture, St...
$ 3500